Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-09

Clinical Trial Update: Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pulmonary rehabilitation in idiopathic pulmonary fibrosis was terminated, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Not specified

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Phase 4 | Status: TERMINATED | Results posted: 2021-06-09